title: Developmental changes in endothelial vasoactive and angiogenic growth factors in the human perinatal lung.
abstract: Little is known of the mechanisms underlying the marked fall in pulmonary vascular resistance that occurs at birth, but changes in the expression of endothelial vasoactive and angiogenic factors during lung development might play a key role. Nitric oxide, endothelin-1, and vascular endothelial growth factor have critical effects on vascular tone and cell growth. Here, we investigated the protein expression of endothelial nitric oxide synthase, endothelin-1 and its receptors, and vascular endothelial growth factor in pulmonary necropsy samples from 14 fetuses of different gestational ages and from 5 infants. Expression of endothelin-1 and its receptor endothelin-A was strong and stable. In contrast, expression of the endothelin-B receptor was weak in early gestation, then increased markedly in mid-gestation and remained high thereafter. The expression of endothelial nitric oxide synthase and vascular endothelial growth factor fell markedly after mid-gestation and remained low thereafter. These data point to a discrepancy between maturational and functional changes in human pulmonary vascular structures. The weak perinatal expression of endothelial nitric oxide could suggest that other potent vasodilatory mediators are responsible for the marked vasodilation observed at birth.
authors.affiliation: Laboratoire d'Immunopathologie Pulmonaire UPRES EA220, UFR Biomedicale des Saints Pères, 75006 Paris, France. marilyne.levy@nck.ap-hop-paris.fr
authors.forename: Marilyne
authors.initials: M
authors.lastname: Levy
authors.forename: Christelle
authors.initials: C
authors.lastname: Maurey
authors.forename: Bernadette
authors.initials: B
authors.lastname: Chailley-Heu
authors.forename: Jelena
authors.initials: J
authors.lastname: Martinovic
authors.forename: Francis
authors.initials: F
authors.lastname: Jaubert
authors.forename: Dominique
authors.initials: D
authors.lastname: Israel-Biet
mesh_terms: D015153:Blotting, Western; D019332:Endothelin-1 / Q000096:biosynthesis / Q000378:metabolism; D004730:Endothelium, Vascular / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D018507:Gene Expression Regulation, Developmental; D005865:Gestational Age; D006133:Growth Substances / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008168:Lung / Q000196:embryology* / Q000378:metabolism*; D008297:Male; D018919:Neovascularization, Physiologic; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III; D044022:Receptor, Endothelin A / Q000378:metabolism; D044023:Receptor, Endothelin B / Q000378:metabolism; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
chemical_list: D019332:Endothelin-1; D006133:Growth Substances; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; D042461:Vascular Endothelial Growth Factor A; D009569:Nitric Oxide; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III